methylprednisolone and semaglutide interactions to avoid VisualAbstract: Oral methylprednisolone may reduce

In STEP 1, participants without diabetes who received semaglutide 2.4 mg weekly lost an average of 14.9% of their body weight over 68 weeks compared to 2.4% with placebo

I am therefore requesting review at the employer level , rather than through the insurers standard appeal process, which does not evaluate medical necessity when a categorical exclusion applies

Staying well hydrated

Dehydration and electrolyte imbalances commonly accompany GLP-1 receptor agonist therapy, particularly when gastrointestinal side effects such as vomiting or diarrhoea are present

From a broader perspective, digital health tools are also shaping how patients manage chronic conditions